Enhancing Disease Surveillance and Pharmacovigilance Practices for RTS,S/AS01E Malaria Vaccine Rollout in Ghana, Kenya, and Malawi: Strategies, Impact, Challenges, and Lessons Learned - Summary - MDSpire

Enhancing Disease Surveillance and Pharmacovigilance Practices for RTS,S/AS01E Malaria Vaccine Rollout in Ghana, Kenya, and Malawi: Strategies, Impact, Challenges, and Lessons Learned

  • By

  • Valérie Haine

  • Tene-Alima Essoh

  • Caroline Perrin Franck

  • Miloje Savic

  • July 14, 2026

Share

Objective:

To enhance disease monitoring and pharmacovigilance during the rollout of the RTS,S/AS01E malaria vaccine in Ghana, Kenya, and Malawi, focusing on healthcare professionals' training and tool development.

Approach:
  • Training and Tools: Tailored trainings and practical tools, including both paper-based and digital formats, were developed for healthcare professionals to improve knowledge and reporting of adverse events.
  • Capacity Building: The initiative aimed to strengthen pharmacovigilance systems through active safety surveillance and predefined adverse events of interest.
Key Findings:
  • Trainings were well received but faced challenges such as resource limitations and over-familiarity with materials.
  • Limited uptake of newly introduced digital tools was noted.
Interpretation:

The strategies and challenges encountered during the RTS,S/AS01E rollout may inform future pharmacovigilance initiatives in similar contexts.

Limitations:
  • Resource limitations affected training effectiveness.
  • Over-familiarity with training materials may have reduced engagement.
Conclusion:

Insights gained from this initiative could support future capacity-building efforts in low- and middle-income countries for safer vaccine implementation.

Original Source(s)

Related Content